Interval to Recurrence Affects Survival in Recurrent Head and Neck Squamous Cell Carcinoma
Cancer Diagnosis & Prognosis · 01.09.2024 · 4 (5) · 658-666
DOI: 10.21873/cdp.10378 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Diagnosis & Prognosis, online erschienen am 01.09.2024. Verfasst von Mioko Matsuo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background/Aim: Approximately half of head and neck squamous cell carcinoma (HNSCC) cases recur, with most recurrences occurring within the first two years after treatment. Although it has been suggested that the interval to recurrence after radical treatment is associated with prognosis in patients with HNSCC, further investigation is needed. Patients and Methods: Patients diagnosed with HNSCC at Kyushu University Hospital were retrospectively analyzed (n=500). Early recurrence (ER) was defined as disease recurrence within six months of radical treatment, whereas late recurrence (LR) was defined as recurrence after more than six months. Continuous variables were assessed using the Mann–Whitney U-test and categorical variables were assessed using Fisher’s exact test.
Results
A total of 234 patients experienced recurrence, with 110 and 124 patients experiencing ER (recurrence within two to six months) and LR (recurrence after six months), respectively. Multivariate analyses identified two independent risk factors for poor prognosis: ER [hazard ratio (HR)=3.200, 95% confidence interval (CI)=1.570-6.521, p=0.001] and absence of radiotherapy (HR=0.374, 95%CI=0.191-0.733, p=0.004). In patients with recurrent HNSCC, a short interval to recurrence is a risk factor for poor prognosis and survival. This study demonstrated the prognostic value of ER in these patients.
Conclusion
The selection of treatment for patients with recurrent head and neck squamous cell carcinoma should consider the timing of recurrence, the initial treatment regimen, and the strategy for changing salvage therapy depending on the recurrence status.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otorhinolaryngology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Zitieren
APA
Matsuo, M., Hashimoto, K., Kogo, R., Sato, M., Manako, T., & Nakagawa, T. (2024). Interval to Recurrence Affects Survival in Recurrent Head and Neck Squamous Cell Carcinoma. Cancer Diagnosis & Prognosis, 4(5), 658-666. https://doi.org/10.21873/cdp.10378
Vancouver
Matsuo M, Hashimoto K, Kogo R, Sato M, Manako T, Nakagawa T. Interval to Recurrence Affects Survival in Recurrent Head and Neck Squamous Cell Carcinoma. Cancer Diagnosis & Prognosis. 2024;4(5):658-666. doi:10.21873/cdp.10378
BibTeX
@article{Matsuo2024,
author = {Matsuo, Mioko and Hashimoto, Kazuki and Kogo, Ryunosuke and Sato, Masanobu and Manako, Tomomi and Nakagawa, Takashi},
title = {Interval to Recurrence Affects Survival in Recurrent Head and Neck Squamous Cell Carcinoma},
journal = {Cancer Diagnosis & Prognosis},
year = {2024},
volume = {4},
number = {5},
pages = {658--666},
doi = {10.21873/cdp.10378}
}
EUVIMED